49 -12 (74) 2024 - Askarova N.A., Matkarimov S.R. - “CLINICAL CASE OF A PATIENT WITH POST-COVID ALLERGIC DERMATITIS”

“CLINICAL CASE OF A PATIENT WITH POST-COVID ALLERGIC DERMATITIS”

Askarova N.A. - Multidisciplinary clinic of the center for the development of professional qualifications of medical workers.

Matkarimov S.R. - Multidisciplinary clinic of the center for the development of professional qualifications of medical workers.

Fayzieva N.N. - Multidisciplinary clinic of the center for the development of professional qualifications of medical workers.

Resume

This article presents a clinical case of the development of papulovesicular rashes in a patient with coronavirus infection COVID-19, which, according to our observations, are the most common skin manifestations of this disease. The timing of the appearance of rashes with COVID-19 is described. The effectiveness of Ezofasfin and TAD, prescribed in addition to therapy, was shown and as a result, already on the 2nd day after therapy, the patient’s condition began to improve, no new rashes were observed, itching decreased, and the recovery process accelerated

Key words: Key words: papulovesicular rashes, period of appearance, therapy, COVID 19

First page

261

Last page

265

For citation:Askarova N.A., Matkarimov S.R., Fayzieva N.N. - “CLINICAL CASE OF A PATIENT WITH POST-COVID ALLERGIC DERMATITIS”//New Day in Medicine 12(74)2024 261-265 https://https://newdayworldmedicine.com/en/new_day_medicine/12-74-2024

List of References

  1. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (03.06.20). Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostikailechenienovoikoronavirusnoiinfektsii (COVID-19). Versiya (03.06.20). (InRuss.)
  2. Очаги гиперпигментации после регресса папуло-везикулезных высыпаний. Fig. 3. Focuses of hyperpigmentation after regression of papulo-vesicular rashes. Клиническаядерматологияивенерология 2021, Т. 20, № 4 СлучайизпрактикиCasestudy 5. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. //J Eur Acad Dermatol Venereol. 2020;34(6):244-245. https://doi.org/10.1111/jdv.16472
  3. Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M. Vascular skin symptoms in COVID-19: a french observational study. //J Eur Acad Dermatol Venereol. 2020;34(9):451-452. https://doi.org/10.1111/jdv.16544
  4. Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. //J Eur Acad Dermatol Venereol. 2020; 34(6):250-251. https://doi.org/10.1111/jdv.16474
  5. Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;1-6. https://doi.org/10.1007/s12250-020-00207-4
  6. Gianotti R. COVID 19 and the skin-heuristic review, Dermo Sprint. 2020. April. In press.
  7. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G. Clinical Characteristics of Coronavirus Disease 2019 in China. //N Engl J Med. 2020;382(18):1708-1720. https://doi.org/10.1056/NEJMoa2002032
  8. Madigan LM, Micheletti RG, Shinkai K. How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic. //JAMA Dermatol. 2020. https://doi.org/10.1001/jamadermatol.2020.1438
  9. Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with Coronavirus Disease 2019? //J Eur Acad Dermatol Venereol. 2020;34(6):246-247. https://doi.org/10.1111/jdv.16471
  10. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. //J Eur Acad Dermatol Venereol. 2020;34:e212. https://doi.org/10.1111/jdv.16387

    file

    download